EUVIMEDEUVIMED entdecken
Crossref

Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief

Mengying He, Mengyao Zhang, Tao Xu, Shujuan Xue, Dazhao Li, Yanan Zhao, Feng Zhi, Dawei Ding

Journal of Controlled Release · 2024-04 · 368 · 233-250

DOI: 10.1016/j.jconrel.2024.02.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-04. Verfasst von Mengying He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Neuropsychiatric Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China. Hauptthemen laut MEDLINE: B7-H1 Antigen, Neoplasms. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor hypoxia impairs the generation of reactive oxygen species and the induction of immunogenic cell death (ICD) for photodynamic therapy (PDT), thus impeding its efficacy and the subsequent immunotherapy. In addition, hypoxia plays a critical role in forming immunosuppressive tumor microenvironments (TME) by regulating the infiltration of immunosuppressive tumor-associated macrophages (TAMs) and the expression of programmed death ligand 1 (PD-L1). To simultaneously tackle these issues, a MnO2-containing albumin nanoplatform co-delivering IR780, NLG919, and a paclitaxel (PTX) dimer is designed to boost photodynamic immunotherapy. The MnO2-catalyzed oxygen supply bolsters the efficacy of PDT and PTX-mediated chemotherapy, collectively amplifying the induction of ICD and the expansion of tumor-specific cytotoxic T lymphocytes (CTLs). More importantly, hypoxia releif reshapes the immunosuppressive TME via down-regulating the intratumoral infiltration of M2-type TAMs and the PD-L1 expression of tumor cells to enhance the infiltration and efficacy of CTLs in combination with immune checkpoint blockade (ICB) by NLG919, consequently eradicating primary tumors and almost completely preventing tumor relapse and metastasis. This study sets an example of enhanced immunotherapy for breast cancers through dual ICD induction and simultaneous immunosuppression modulation via both hypoxia relief and ICB, providing a strategy for the treatment of other hypoxic and immunosuppressive cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenNeoplasmsHumansManganese CompoundsTumor MicroenvironmentOxidesImmunotherapyImmunosuppressive AgentsHypoxiaCell Line, Tumor

Stichwörter der Autor:innen

Hypoxia reliefImmune checkpoint blockadeImmunosuppressive tumor microenvironmentPhotodynamic immunotherapyTumor-associated macrophages

Substanzen

B7-H1 AntigenManganese CompoundsOxidesImmunosuppressive Agents

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Neuropsychiatric Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.
  • Jiangsu Key Laboratory of Neuropsychiatric Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI),…
  • Department of Neurosurgery, The First People's Hospital of Changzhou, Changzhou 213003, China; Clinical Medical Research Center, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
  • Department of Neurosurgery, The First People's Hospital of Changzhou, Changzhou 213003, China; Clinical Medical Research Center, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China. Electronic a…
  • Jiangsu Key Laboratory of Neuropsychiatric Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China. Electronic address: dawei.ding@suda.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

He, M., Zhang, M., Xu, T., Xue, S., Li, D., Zhao, Y., Zhi, F., & Ding, D. (2024). Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief. Journal of Controlled Release, 368, 233-250. https://doi.org/10.1016/j.jconrel.2024.02.030

Vancouver

He M, Zhang M, Xu T, Xue S, Li D, Zhao Y, et al. Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief. Journal of Controlled Release. 2024;368:233-250. doi:10.1016/j.jconrel.2024.02.030

BibTeX
@article{He2024,
  author = {He, Mengying and Zhang, Mengyao and Xu, Tao and Xue, Shujuan and Li, Dazhao and Zhao, Yanan and Zhi, Feng and Ding, Dawei},
  title = {Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {368},
  pages = {233--250},
  doi = {10.1016/j.jconrel.2024.02.030}
}
Kostenlos starten →